Soleus Capital Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
Other funds holding APRE
ACM
Soleus Capital Management's APRE Position: Q3 2026 in Review
Soleus Capital Management opened a new position in Aprea Therapeutics (APRE) in Q3 2026: 1,000,000 shares worth $750K. The stake represents 0.03% of the portfolio and ranks #84 among its holdings.
27 funds tracked by Wall St. Rank hold APRE as of Q3 2026.
- Soleus Capital Management held 1,000,000 shares of Aprea Therapeutics worth $750K as of Q3 2026.
- Aprea Therapeutics was a new Soleus Capital Management position in Q3 2026.
- Aprea Therapeutics made up 0.03% of Soleus Capital Management's portfolio in Q3 2026, its #84 holding.
- 27 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2026.
Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.